Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".

Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, Kinoshita M, Kojima S, Shen H, Uehara T, Hosogaya N, Iwanaga N, Mukae H

Open source

DOI
10.1007/s40121-024-01054-6
Published
2024 Nov
Container
Infectious diseases and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40121-024-01054-6,
  title = {Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".},
  author = {Takazono T and Fujita S and Komeda T and Miyazawa S and Yoshida Y and Kitanishi Y and Kinoshita M and Kojima S and Shen H and Uehara T and Hosogaya N and Iwanaga N and Mukae H},
  year = {2024},
  journal = {Infectious diseases and therapy},
  doi = {10.1007/s40121-024-01054-6},
  url = {https://doi.org/10.1007/s40121-024-01054-6}
}

RIS

TY  - JOUR
TI  - Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".
AU  - Takazono T
AU  - Fujita S
AU  - Komeda T
AU  - Miyazawa S
AU  - Yoshida Y
AU  - Kitanishi Y
AU  - Kinoshita M
AU  - Kojima S
AU  - Shen H
AU  - Uehara T
AU  - Hosogaya N
AU  - Iwanaga N
AU  - Mukae H
PY  - 2024
JO  - Infectious diseases and therapy
DO  - 10.1007/s40121-024-01054-6
UR  - https://doi.org/10.1007/s40121-024-01054-6
ER  - 

APA

T, T., S, F., T, K., S, M., Y, Y., Y, K., M, K., S, K., H, S., T, U., N, H., N, I., & H, M. (2024). Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".. Infectious diseases and therapy. https://doi.org/10.1007/s40121-024-01054-6

Source records